SCHEMBL7690630

SCHEMBL7690630

CCCCOc1c(C)cccc1C(=O)N1CCN(C(Cc2ccc(C#N)c(Oc3cccc(C)n3)c2)c2cnc(C)[nH]2)CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.35
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HTT P42858 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
SCN9A Q15858 1/20 0.32
GAA P10253 1/20 0.32
CLK1 P49759 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
USP2 O75604 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
HSD17B10 Q99714 1/20 0.31
XDH P47989 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7683709 0.93 ALDH1A1 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7689761 0.92 FFAR4 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7690259 0.91 FFAR4 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7688314 0.90 FFAR4 (0.35) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7681535 0.89 GRM2 (0.32) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7621679 0.88 FNTA (0.37) KDM4EALDH1A1HTTSMN1; SMN2SCN9A
SCHEMBL7690278 0.88 FFAR4 (0.36) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7685752 0.87 HTT (0.42) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7683737 0.85 KDM4E (0.39) FFAR4KDM4EALDH1A1HTTSMN1; SMN2
SCHEMBL7626194 0.82 CBX7 (0.39) KDM4EALDH1A1HTTSMN1; SMN2SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020052363-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-05-02 US claimed
WO-2001060369-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2001-08-23 WO claimed
US-20020052363-A1 Inhibitors of prenyl-protein transferase DINSMORE CHRISTOPHER J (US) 2002-05-02 US disclosed
WO-2001060369-A1 INHIBITORS OF PRENYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 2001-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020052363-A1 Inhibitors of prenyl-protein transferase FNTA, FNTB, PTAR1 FFAR4 4314/4885KDM4E 2677/4885ALDH1A1 1461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.